expert reaction to announcement (not published study) of topline results from the TRIUMPH-1 Phase 3 clinical trial of Retatrutide (opens in new tab)
Scientists comment on topline results from a phase III clinical trial of the hormone receptor agonist Retatrutide. Dr Marie …
Read the original article